2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
Sex and gender differences in myocarditis and dilated cardiomyopathy: an update
DL Fairweather, DJ Beetler, N Musigk… - Frontiers in …, 2023 - frontiersin.org
In the past decade there has been a growing interest in understanding sex and gender
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …
2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with …
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …
Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика …
ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …
VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure
Objectives: The purpose of this study was to evaluate the renal effects of sacubitril/valsartan
in patients with heart failure and reduced ejection fraction. Background: Renal function is …
in patients with heart failure and reduced ejection fraction. Background: Renal function is …
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Background We compared the angiotensin receptor–neprilysin inhibitor LCZ696 with
enalapril in patients who had heart failure with a reduced ejection fraction. In previous …
enalapril in patients who had heart failure with a reduced ejection fraction. In previous …
2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction …
Abstract The 2017 ACC/AHA/Heart Failure Society of America (HFSA) heart failure (HF)
guidelines (1) reflect a focused update of the ACC/AHA 2013 HF guidelines (2) and include …
guidelines (1) reflect a focused update of the ACC/AHA 2013 HF guidelines (2) and include …
The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications
K Kuwahara - Pharmacology & therapeutics, 2021 - Elsevier
Natriuretic peptides, which are activated in heart failure, play an important cardioprotective
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
Background—Clinical trials in heart failure have focused on the improvement in symptoms
or decreases in the risk of death and other cardiovascular events. Little is known about the …
or decreases in the risk of death and other cardiovascular events. Little is known about the …